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abstract: Triploidy is a relatively common cause of miscarriage; however, recurrent triploidy has rarely been reported. A healthy 34-year-
oldwomanwas ascertained because of 18 consecutivemiscarriageswith triploidy found in all 5 karyotyped losses.Molecular results in a sixth loss
were also consistent with triploidy. Genotyping of markers near the centromere onmultiple chromosomes suggested that all six triploid concep-
tuses occurred as a result of failure to completemeiosis II (MII). The proband’smother had also experienced recurrentmiscarriage,with a total of
18 miscarriages. Based on the hypothesis that an inherited autosomal-dominant maternal predisposition would explain the phenotype, whole-
exome sequencing of the proband and her parents was undertaken to identify potential candidate variants. After ﬁltering for quality and rarity,
potentially damaging variants sharedbetween theproband andhermotherwere identiﬁed in 47 genes. Variants in genes coding for proteins impli-
cated in oocytematuration, oocyte activation or polar body extrusionwere then prioritized. Eight of themost promising candidate variants were
conﬁrmed by Sanger sequencing. These included a novel change in the PLCD4 gene, and a rare variant in theOSBPL5 gene, which have been impli-
cated inoocyte activation upon fertilization and completionofMII. Several variants in genes codingproteins playing a role inoocytematuration and
early embryonic development were also identiﬁed. The genes identiﬁedmay be candidates for the study in other women experiencing recurrent
triploidy or recurrent IVF failure.
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Introduction
Triploidy is one of the more common abnormalities to occur in preg-
nancy and accounts for1%of conceptions and10%of early spontan-
eous abortions (SAs) (Hassold et al., 1980). It occurs independently of
maternal age and may be the result of either digyny (extra haploid set
from mother) or diandry (extra haploid set from father) (McFadden
and Kalousek, 1991). Digynic triploidy predominates in cases with iden-
tiﬁable fetuseswhile diandry is slightlymore common in early triploid SAs
that lack embryos (McFadden and Kalousek, 1991). Some mechanisms
for the occurrence of triploidy include failure to extrude the ﬁrst polar
body (PB) at maternal meiosis I (MI); failure to divide or failure to
extrude the second PB at meiosis II (MII) or, in the case of diandry, poly-
spermy (McFadden and Langlois, 2000; Zaragoza et al., 2000;McFadden
et al., 2002).While failure of paternalMI orMII could result in fertilization
by a diploid sperm (Zaragoza et al., 2000; Rosenbusch, 2008), there is
no conclusive molecular data to support that such sperm contribute to
triploid pregnancies (McFadden et al., 2002).
There is little evidence for a propensity to recurrence of triploidy in
the general population (Robinson et al., 2001). Hence, the occurrence
of two triploid pregnancies from one parent is usually attributed to
chance. Recurrent triploidy, deﬁned as three or more triploid concep-
tions from one couple, has rarely been reported. Pergament et al.
(2000) reported on a woman with two triploid pregnancies, with an
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additional 2 triploid embryos identiﬁed from 13 embryos produced
after IVF using ICSI. It was inferred that these were due to errors of
MII division because the oocytes showed the presence of one PB and
only two pronuclei were observed at fertilization (Pergament et al.,
2000). Brancati et al. (2003) reported on a 36-year-old woman with
three consecutive digynic triploid pregnancies consistent with either
maternal MI or MII errors. Huang et al. (2004) similarly reported on a
woman who at age 31 had had three triploid losses, all of which were
determined to be due to maternal MII errors. An additional case
with three triploid losses was reported in a mother with low level 45,
X mosaicism, but molecular testing was not performed in this case
(Johnson et al., 2000).
We hereby report a case with at least six triploid conceptions, each
consistent with a failure of maternal MII. A number of rare genetic
variants were identiﬁed by whole-exome sequencing, and we discuss
the possible candidates responsible for this phenotype.
Materials andMethods
Ethics statement
Ethics approval for this study was obtained from the University of British
Columbia Clinical Research Ethics Board (H01-70460, Study of Epigenetics
of Reproduction and Fertility; H12-00145, Imprinting in Placenta).
Patient and family history details
The proband at age 34 had experienced 18 consecutive SAs all between 5.5
and 12 weeks of gestation and no live births (G18SA18). Her ﬁrst loss was at
age 26. Five SAswerekaryotypedwith threebeing diagnosed as 69,XXXand
two as 69, XXY. A sixth loss was evaluated by diagnostic array comparative
genomic hybridization (oligo-based array) after culture failure and did not
show aneuploidy, but triploidy cannot be detected with this approach.
Parental karyotypes were normal. Normal test results were obtained for
anticardiolipin antibodies, lupus anticoagulant, thrombophilia screen and
thyroid-stimulating hormone. The proband is otherwise in good health and
had no difﬁculty conceiving. There is no reported consanguinity. The pro-
band’s family history is signiﬁcant in that the proband’s mother, who is also
otherwise healthy, was reported to have had 18 SAs, as well as 2 live births
(the proband and her brother). The reproductive history of the brother is
unknown. The maternal grandmother was not thought to have experienced
recurrent miscarriage.
Previous investigations for amutation inNLRP7 and C6orf221 (KHDC3L) in
the proband were negative (Manokhina et al., 2013).
Molecular genotyping
DNAwasextractedusing standardprocedures fromall six available chorionic
villus samples from miscarriage specimens, as well as from blood samples
from the proband and both of her parents. Parental and meiotic origin of
the extra set of chromosomes was determined by comparing microsatellite
marker inheritance patterns in the triploid placenta to that of the maternal
DNA as we have done previously (McFadden et al., 2002; McFadden and
Robinson, 2006). Markers used to distinguish MI from MII errors mapped
near (,5 centiMorgans (cM) from the centromere (http://cedar.genetics.
soton.ac.uk/pub) and were from multiple chromosomes (Table I). Digyny
is expected to be associated with inheritance of either both maternal
alleles or a double dose of one maternal allele at all loci, whereas diandry
would be expected to show two copies of a non-maternal allele. Digyny as
the result of an MI error should show non-reduction at all centromeric
markers, while a failure of MII should show reduction to homozygosity at
all markers near the centromeres.
Methylation analysis
Recurrent triploidy has been suggested to be a consequence ofNLRP7muta-
tion in some cases (Slim et al., 2011), and NLRP7mutations have been asso-
ciated with the loss of maternal methylation imprints; therefore, we wanted
to conﬁrm that such methylation imprints were set appropriately in these
cases. We estimated methylation at the following imprinting control
regions: H19 (ICR1), KvDMR1 (ICR2) and SGCE by pyrosequencing. The
assays used and results in normal placenta were described previously
(Bourque et al., 2011).
Whole-exome sequencing
Whole-exome sequencing on the proband and both her parents was per-
formed by Perkin Elmer using the Illumina Hiseq 2000 machine for 100 bp
Paired end sequencing (Instrument control software 1.4.8; RTA version
1.12.4.2). Following targeted enrichment using the SureSelect (Agilent Tech-
nologies Canada, Inc.) 50 Mb v3 Capture kit, we obtained a yield of 20–
22 Gb of sequence data (84 000 000 reads) per individual. The mean
exome coverage was 89-fold, with at least 80% of the exome covered
more than 30 times. Mapping to the reference genome sequence (hg19)
and alignment was done using both Bowtie and BWA algorithms in order
to effectively align reads with substitutions as well as short indels. The
–m1 option speciﬁes bowtie to discard any reads that can be mapped to
more than one location. Using samtools, sam.ﬁles were then converted to
bam.ﬁles removing unaligned reads as well as alignments with a quality
lower than a Phred quality score at 20 for the entire read. For local realign-
ment, we used the GATK aligner, which searches for missing deletions in
Bowtie + BWA procedure to reduce false positives. Variant calling was per-
formed by using samtools mpileup. Single-nucleotide variants were ﬁltered
for minimum mapping quality of a Phred quality score at 30 allowing 99.9%
base call accuracy.
The variantswere annotated based on their frequency in the overall popu-
lation and as being ‘known’ or ‘novel’ according to whether they had been
reported in the public databases dbSNP or 1000 Genomes, variants were
further assessed for their potential to disrupt protein function using the
software ‘Sorting Intolerant from Tolerant’ (SIFT) (http://sift.bii.a-star.
edu.sg/www/SIFT_AWS_help.html) (Ng and Henikoff, 2003), PolyPhen-2
(Adzhubei et al., 2010) and Mutation Taster (Schwarz et al., 2014). We
deleted non-exonic variants and variants indicated as synonymous to
obtain 10 000–15 000 rare (,0.01 minor allele frequency (MAF)) or novel
variants for each individual. Given the hypothesized autosomal-dominant
nature of the predisposition, heterozygous variants shared between the
proband and her mother and not present in the father were ﬁltered.
Conﬁrmational Sanger sequencing
Eight selected rare non-synonymous candidates were conﬁrmed using
Sanger sequencing. An additional set of 17 blood DNA samples derived
fromwomenwith a documented singleMII digynic triploid pregnancy, ascer-
tained as part of a previous study of origin of triploidy (McFadden and Rob-
inson, 2006), was sequenced with primers for these candidate variants in
order to test for the recurrence of the detected variants for the stratiﬁed
population.
Primers were created using the Primer3 v0.4.0 software (http://bioinfo.
ut.ee/primer3-0.4.0) and the UCSC reference genome (GRCh37/hg19).
Primer sequences were as follows:MBD4, F: TACTGTCCCCCAGCAAAC
AT, R: CACTAGGCTTCTAGTTGGGCTAA; OSBPL5, F: CTTCCGGTGT
GCAGGATGT, R: AGGTGTTGTTCCCAGATGCT; PLCD4, F: CAAGAA
AAGCAACCCAGTCA, R: CATTAGGAAGGCAGCCAGAG; YES1, F: GA
GGATATGGATTTTGTCCTCA, R: TCCCAGTCCATTCTTACTGACA;
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Table I Molecular genotyping results for the proband, her parents and six SAs.
Marker Chromosomal
band
Map start position
(hg19)
Distance to
centromere
(cMa)
Proband
mother
Proband
father
Proband SA5
69,
XXY
SA10 SA11
69,
XXX
SA16
69,
XXX
SA17
69,
XXY
SA18
69,
XXY
Inferred
partner
genotype
DXS1003 Xp11.3 46419301 ab a aa aa ui aaa ui aaa ui aaa ui aa ui aa ui a
DXS6941 Xp11.3 48235256 aa a aa aa ui aaa ui aaa ui aaa ui aa ui aa ui a
AR Xq11.2 66800000 1 bc a ab bb R bbc R bbc R aac R aa R NA c
D3S1271 3q12.3 100734730 1 bb ab ab aab ui aab ui aaa R aab R aab ui bbb R ab
D5S822 5q11.1 50511131 <1 ab ac bc bbb R bbb R bbc ui bbb R bcc ui ccc R bc
D12S87 12p11.2 30387939 <5 de ab be dee R bbc R bbd R bbc R dee R cee R cd
D13S141 13q12.11 20724459 <5 ab bb ab aab ui aaa R aab ui aaa R aaa R aaa R aa or ab
D13S175 13q12.11 20848380 ,5 bc cc bc bbc R bbb R abb ui bbb R bbb R bbb R ab or bb
D13S1236 13q12.11 22695996 be cd de ade N aee R cee R aee R aee R aee R ac
D13S115 13q12.11 22842462 dd ac cd bcd N bdd R ddd R bcd N bdd R bdd R bd
D13S232 23799762 ab cd bc bcd N bbd R bbd R bcd N bbd R bbd R dd?
D16S403 16p12.2 23037651 dd bc bd abd N abd N abb R abd N bbd ui bdd ui ab or ad
D16S401 16p12.1 24685957 ac bc cc acc ui acc ui acc ui acc ui acc ui acc ui aa?
D16S3093 16p12.1 26745405 ab bb bb bbd ui bbd ui bbd ui bbd ui bbc ui bbc ui cd
D16S753 16p11.2 31273504 <2 bd cc bc NA NA acc R acc R ccc R bbc R ac
D16S3105 16q12.1 46792100 <2 aa aa aa aaa ui aaa ui aaa ui aaa ui aaa ui aaa ui aa?
D16S3044 16q12.1 47437536 <2 bd ab bd dde R dde R bbe R bbe R bbc R bcd N ce
D16S409 16q12.1 48775854 bb ab ab bbb R bbb R aab ui aab ui aab ui abb ui ab or bb
D16S515 16q23.1 76517028 ab cd ad acd N acd N acd N acd N aad ui aad ui cd or ac
D16S402 16q13.3 83293414 ad cc ac abc N aac ui acc ui acc ui abc N abc N ab or bc
D18S1093 18q12.2 34019263 ad cd ad acd N acd N abd N abd N acd N aac R bc
D18S1127 18q21.2 53371163 bd ad bd dde R bde N bcd N cdd R bde N bbe R ce
D18S488 18q22.3 69404462 bd ee de cde N cde N ade N cee R cde N ade N ac
D22S686 22q12.2 21393073 ab ac ac aaa R aac ui aaa R aac ui aac ui aaa R aa or ac
D22S277 22q13.2 34543413 ad bc cd cdd ui acd N cdd ui cdd ui acd N acd N ac or ad
For all cases and all informative centromeric markers (bolded), there was a reduction of maternal heterozygosity to homozygosity. Microsatellite genotyping results are designated by a letter with ‘a’ being the largest amplicon. For SAs, the
transmission of maternal heterozygosity is indicated as N (non-reduced), R (reduced) or ui (uninformative).
aCentimorgans.
C
andidate
variants
leading
to
recurrenttriploidy
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NLRP10, F: AGCAGACCACCCAGCAAA, R: ACGTGCTCCCTTCTCAT
CAC; BNC2, F: TTCGGAGGGAGCTAAAGACC, R: CGAAGTTTCTCCC
ACACCTT; CSF-1R, F: AGGGAAGAGCCAGAAAGGAG, R: AAGTGCT
GGGAGGGCTTG; CEP250, F: CTGGGGCAAGAGAGAGAAGA, R: CC
AGGACAGAGGCTTGTAGG. Sequencing reactions were performed
with the Big Dye Terminator v3.1, run on an Applied Biosystems 3730xl
DNA Analyzer (Life Technologies, USA), and evaluated with Chromas
2.33 (TechnelysiumPtyLtd,Australia) andSeqDoC(Crowe, 2005) software.
Results
Amaternal MII origin of triploidy
Molecular genotyping results are shown in Table I. Although paternal
DNA was not available, the genotype could be inferred at many loci.
All markers were consistent with maternal origin of the extra haploid
set of chromosomes. As three alleles were observed atmany loci, endo-
reduplication of one pronucleus could be excluded and a maternal
meiotic error could be inferred. A subset of microsatellite markers
was chosen based on being very near (,5 cM) to the centromere. For
all cases and all informative centromeric markers, there was a reduction
of maternal heterozygosity to homozygosity, indicating that the triploids
all resulted from a failure of thematernalMII division. In one case (SA18),
the closest marker to the centromere on 16q (D16S3044) showed non-
reduction, while the closest marker to the centromere on 16p
(D16S753) showed reduction to homozygosity, indicating a recombin-
ation event had occurred close to the centromere. Hence, this case
was uninformative for the chromosome 16 centromere, but all other
centromeric markers in this case were reduced to homozygosity, con-
sistent with maternal MII failure. As the additional marker analysis
demonstrates apparently normal levels of recombination, we assume
that MI was normal.
Normal methylation at imprinted loci
The proband, her mother and ﬁve triploid samples were evaluated for
methylation level at three imprinting control regions: SGCE, H19
(ICR1) and KvDMR1 (ICR2). The triploid samples exhibited values in
the expected range for digynic triploid placental villi (for miscarriages)
(Bourque et al., 2011), while the adult blood samples showed
methylation consistent with that observed for control blood (Penaher-
rera et al., 2010) (Supplementary data, Table SI).
Whole-exome sequencing
All ﬁltered variants were manually inspected for gene function in relation
to the phenotype. Speciﬁcally, genes known or predicted to be involved
in cell cycle regulation, oocyte maturation, MII resumption or extrusion
of the second PB and those involved in other basic cellular functions
were prioritized. Within the prioritized variants, those involving genes
conserved across species and harboring signiﬁcant mutations predicted
to be damaging were considered to be the most promising candidates.
SIFT, PolyPhen-2, MutationTaster and the Human Splice Finder scores
were reviewed for prediction of functional effects of the variants selected.
Public databases, including 1000 Genomes and the exome variant server
from the NHLBI GO Exome Sequencing Project, were reviewed for
MAFs of those variant alleles. PubMed, OMIM, NCBI Gene, EST and Uni-
ProtKBwere reviewed for previous publications regarding candidate genes
and related genes, as well as phenotypes in humans and other species, and
functional and expression data. Reads were inspected for coverage using
the Integrated Genome Browser to assess the likelihood of a variant
being a true call before using Sanger sequencing for validation of selected
variants in the proband and her mother.
We identiﬁed rare non-synonymous candidate variants predicted to
be protein damaging and shared between the proband and her mother
in 47 genes (Supplementary data, Table SII). The literature on gene
expression in ovary or oocyte is heterogeneous and expression
depends on the tissue used, developmental stages as well as the men-
strual cycle, making it difﬁcult to eliminate candidates based on expres-
sion patterns. Over 7000 genes are expressed in the MII oocyte alone
(Kocabas et al., 2006). We selected eight genes for follow-up validation
because they code for proteins known to be involved in cell cycle regu-
lation or oocyte maturation (CSF1R, MIM 164770;MBD4, MIM 603574;
BNC2, MIM 608669; CEP250, MIM 609689) or to be involved in MII re-
sumption and extrusion of the second PB (PLCD4, MIM605939;OSBPL5,
MIM 606733; YES1, MIM 164880) (Table II). We also studied NALP10
(MIM 609662) because it is closely related to the NALP gene family
that was reported to be required for early embryonic development in
the mouse and potentially involved in reproductive disorders in humans
.............................................................................................................................................................................................
Table II Eight candidate genes involved in cell cycle regulation or oocytematurationwith rare non-synonymous candidate
variants that are shared between the proband and her mother.
Gene Single nucleotide
polymorphism
Minor allele
frequency
Protein
change*
Protein
damage
PLCD4 Phospholipase C, delta 4 2,219501020,1,T/C Novel L696P Damaging
OSBPL5 Oxysterol binding protein-like 5 11,3123481,1,C/G Novel G385R Damaging
YES1 Proto-oncogene tyrosine-protein kinase Yes 18,745840,1,T/C C: 0.009 I198V Tolerant
MBD4 Methyl-CpG-binding domain protein 4 3,129150385,1,C/G G: 0.004 D250H Damaging
CSF1R Colony stimulating factor 1 receptor 5,149435645,1,G/A Novel T833M Damaging
NLRP10 NOD-like receptor family pyrin-domain containing 10 11,7982144,1,C/A A: ,0.001 D339Y Damaging
CEP250 Centrosomal protein 250 kDa 20,34092555,1,A/G G: 0.006 N2120D Not scored
BNC2 Zinc ﬁnger protein basonuclin-2 9,16436952,1,G/C C: 0.009 L414V Tolerant
*Refers to: NP_116115.1 (PLCD4); NP_001137535.1, NP_663613.1 (OSBPL5); NP_005424.1 (YES1); NP_001263202.1 (MBD4); NP_001275634.1, NP_005202.2 (CSFR1);
NP_789791.1 (NLRP10); NP_009117.2 (CEP250); NP_060107.3 (BNC2).
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(Meyer et al., 2009; Peng et al., 2012). The GEO database (http://
www.ncbi.nlm.nih.gov/geoproﬁles/) conﬁrms expression of all candi-
date genes in the oocyte at the germinal vesicle and MII stage in the
mouse, while microarray BIOGPS database (http://biogps.org) show
positive expression in the ovary in normal human tissues.
Follow-up Sanger sequencing
The eight candidate variants were validated in the proband and her
mother. None of the studied candidate variants were detected in the
additional group of 17 samples from women with digynic MII triploid
fetus in their pregnancy history (Table II).
Discussion
As triploidy is relatively common at conception, experiencing two cases
of triploid miscarriage is most often due to chance (Robinson et al.,
2001). There are few reports of recurrent (3+) triploidy in the literature
(Pergament et al., 2000; Brancati et al., 2003; Huang et al., 2004). The
present case is distinctive by having more losses in total and more
conﬁrmed triploid losses than any previously reported case. As the pro-
band’s mother had 2 live births from 23 pregnancies, a small number of
eggs may mature and fertilize normally. The patient reported by Perga-
ment et al., had a live birth using IVF and preimplantation genetic screen-
ing (PGS), having had two triploid pregnancies and twoadditional triploid
conceptuses identiﬁed after IVF. Although the clinical utility of PGS is still
debated, the use of IVF may enable the selection of fertilized eggs that
have extruded a second PB and/or are found to be euploid by PGS.
Origin of triploidy
We performed detailed molecular genotyping that demonstrated that
the recurrent triploidy was a consequence of an inherent failure to com-
pleteMII, as has alsobeenobserved in75%of sporadicdigynic triploidy
(McFadden and Langlois, 2000; Zaragoza et al., 2000). Other described
origins for triploidy, including fertilization of a binucleate/diploid [giant]
oocyte (derived from a tetraploid progenitor) and endoreduplication
(Rosenbusch, 2008) were excluded by molecular genotyping.
Usually, MII is initiated immediately after completion of MI during the
oocyte maturation phase. At the time of ovulation, MII is arrested at
metaphase. MII resumes after the sperm enters the egg. Sperm entry
initiates a signaling cascade that likely involves activationof phospholipase
C (PLC) (Suh et al., 2008; Kashir et al., 2010). PLC hydrolyzes phospha-
tidylinositol 4,5-bisphosphate to produce diacyl-glycerol and inositol tri-
sphosphate (IP3). IP3 acts to increase calcium levels, which then triggers
the extrusion of the second PB (Ullah et al., 2014). Digynic triploidy after
assisted reproduction is commonly characterized by non-extrusion of
the second PB and formation of three pronuclei (Grossmann et al.,
1997; Rosenbusch, 2008). Also, in vitro creationof digynic triploid blasto-
cysts is usually performed using cytochalasin-b, an inhibitor of actin
microﬁlaments, which prevents PB extrusion (Niemierko, 1975; Speirs
and Kaufman, 1989). Hence, defects in genes involved in oocyte activa-
tion or PB extrusion can be considered candidates explaining recurrent
triploidy.
Severalmouse strains produceoocytes that arrest inMI and fail to pro-
gress toMII; however, someof these eggs can be activated upon fertiliza-
tion resulting in digynic triploid conceptuses (Kaufman and Speirs, 1987).
The defect in the LT/Sv mouse strain has been linked to a prolonged
spindle assembly checkpoint (Hupalowska et al., 2008). Interestingly,
the ability of the LT/Sv oocytes to become activated upon fertilization
was dependent on the levels of protein kinase C (alpha, delta and zeta)
(Archacka et al., 2008). There have been a number of reports of
women experiencing infertility due to arrest of oocytes at MI (Mrazek
and Fulka, 2003; Heindryckx et al., 2011). Thus, mutations in genes
coding for proteins involved in the oocyte maturation/meiotic cell
cycle regulationmayalsobeconsideredcandidatescontributing to recur-
rent triploidy.
Candidate genes involved in MII resumption/
extrusion of the second PB
The PLCD4 gene encodes a member of the delta class of PLC enzymes.
This gene is predominantly expressed in testes, where it functions in the
acrosome reaction upon fertilization (Fukami et al., 2003). Male mice
with a disruption of PLCD4 produced no or small sized litters and
in vitro fertilization using PLCdelta42/2 sperm resulted in fewer eggs
becoming activated (Fukami et al., 2001). While female mice lacking
this gene were generally fertile, there was a slight reduction in fertility
rates and litter size. Of interest, PLCD4 is speciﬁcally up-regulated in
the mouse oocyte during MII (Oliveri et al., 2007). Furthermore,
mouse eggs injected with IP3, a product of PLC activity, do not emit
the second PB (Kurasawa et al., 1989). The mutation in our patient
could have resulted in increased or decreased activity and/or interfered
with functional PLCD4 in the oocyte, causing a failure of extrusion of the
second PB. Such amutation could also cause increased ability to activate
an immature oocyte arrested at MI, thereby resulting in recurrent
triploidy, rather than infertility in the presence of an independent
oocyte maturation defect.
OSBPL5 encodes a member of the oxysterol-binding protein (OSBP)
family, a group of intracellular lipid receptors that play a key role in the
maintenance of cholesterol balance in the body. Experiments with chol-
esterol depletion in mouse disturbed the subcellular localization of the
signal molecule c-Src, and subsequent inhibition of Src kinase proteins
prevented second PB extrusion (Buschiazzo et al., 2013). Cholesterol
repletion recovered the fertilization index and ability to extrude the
second PB in cholesterol-depleted oocytes, indicating reversibility of
these effects.
Theprotein tyrosine kinaseYES1, the effectormolecule ofPLCD4, also
carried a non-synonymous variant in our case in the highly conserved
SH2 domain. Src-kinases Fyn and Yes were found to be speciﬁcally
up-regulated in mouse oocytes during MII resumption and essential to
this process (Luo et al., 2010). Non-speciﬁc inhibiting Src family kinase
activity blocks MII; in contrast, microinjecting mRNAs of active forms
of signal molecules Fyn or c-Yes into ovulated eggs triggered MII
without evokingCa2+ increase (Reutet al., 2007).Thepatient’smutation
in YES1 is not predicted to have high damaging potential, but given its in-
volvement in the same pathway as PLCD4, it may enhance the pathway
damage in the presence of the PLCD4 mutation.
Candidate genes involved in cell cycle
regulation/oocyte maturation
Asdiscussed, the appearance of a defect inMII could result from a defect
in the timing of oocyte maturation, such that MI, rather than MII, is com-
pleted at the time of sperm activation. Oocyte maturation may be
affected by a wide variety of processes from those affecting growth of
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follicular support cells to those acting inside the egg nucleus itself. Three
protein-coding genes (CSF1R, NALP10, MBD4) potentially involved in
oocytematuration revealed heterozygous variants predicted to be dam-
aging.
CSF1R encodes for the Receptor for Colony Stimulating Factor 1 and
almost exclusivelymediates thebiological effects of this cytokine (Li et al.,
2006). Both CSF1 and CSF1R are expressed at high levels in the mature,
unfertilized oocyte (Witt and Pollard, 1997; Salmassi et al., 2005). Fol-
lowing ovulation and fertilization, receptor mRNAs are degraded to un-
detectable levels (Arceci et al., 1992). CSF1 also regulates cell division in
the blastocyst before implantation and is implicated in the regulation of
trophoblast differentiation and local immune responses protecting the
fetus (Garcia-Lloret et al., 1994; Gorivodsky et al., 1999). Female mice
with a homozygous mutation in CSF1 revealed a reduced fertility rate
(Pollard et al., 1991), although this was thought to involve the implant-
ation stage rather than oocyte development.
NALP10 is a member of the nucleotide-binding domain leucine-rich
repeat containing (NLR) family that serves as major regulators of inﬂam-
matory and innate immune response.Anumberof these familymembers
are expressed in oocyte and involved in reproduction control (Tian et al.,
2009), andNLRP7 is awell-known ‘maternal effect gene’, inwhichbiallelic
mutations are found in women with recurrent biparental hydatidiform
mole (Murdoch et al., 2006) and possibly involved in a wider range of
pregnancy pathology including triploidy (Murdoch et al., 2006; Meyer
et al., 2009; Fallahian et al., 2013). However, NLRP10 does not appear
to be expressed in the oocyte (Tian et al., 2009)
MBD4 (MED1) belongs to a family of proteins with a methyl-binding
domain at the N-terminus that functions both in binding to methylated
DNAand in protein interactions and aC-terminal mismatch-speciﬁc gly-
cosylase domain that is involved inDNArepair. Itwas deemedof interest
as its expression is speciﬁcally up-regulated at MII (Oliveri et al., 2007)
and it is involved in methylation reprogramming in gametogenesis
(Galetzka et al., 2007).
BNC2 encodes basonuclin 2, a transcriptional factor from the group of
‘maternal-effect’ genes in mice (Ma et al., 2006). It may play a role in the
differentiation of spermatozoa and oocytes. Polymorphisms in this gene
were associated with serous ovarian cancer. However, the variant in the
proband and her mother are assessed as ‘tolerated’, suggesting minor
protein damage.
While we did not identify any damaging mutations in genes known to
be involved inmeiotic spindle assembly checkpoints (as implicated in the
MI arrest in the LT/Sv mouse strain), variants predicted to be tolerated
were identiﬁed in genes coding for centrosomal proteins (CEP192,
CEP250) and a spindle associated kinesin protein, KIF9. Although
expressed in MI and MII, knockdown of C-NAP1 (product of CEP250)
in mouse oocytes did not produce an obvious effect onmeiotic progres-
sion (Sonn et al., 2011) and Drosophila mutants lacking centrosomes
can complete MII (Stevens et al., 2007). KIF9 is a regulator of spindle
dynamics and affectsmitotic progression (Andrieu et al., 2012), although
a function in meiosis is unknown.
Summary
In summary, we present a unique patient exhibiting a high number of mis-
carriages and recurrenceof triploid conceptionswith amaternal history of
unusually frequent miscarriages. Hypothesizing an inherited autosomal-
dominant predisposition, we identiﬁed candidate genes potentially
involved in the etiology of recurrent triploidy using whole-exome sequen-
cing.Whilewe cannot concludewhichmutation(s) caused the reproduct-
ive failure in this particular case, a limited numberof reasonable candidates
playing a role inoocytematuration,oocyteactivationorPBextrusionwere
identiﬁed.This shows the great potential of studying familieswith rarephe-
notypes to increase our knowledge about mechanisms of reproductive
failure. Future patients with recurrent triploidy or recurrent IVF failure
due to failed oocyte maturation could be screened for mutations in
these same genes in order to conﬁrm our ﬁndings. However, considering
genetic heterogeneity and complexity, establishing animal models may be
the most reasonable approach in the future for studying the functional
impact of variants in genes involved in human reproduction.
Supplementary data
Supplementary data are available at http://molehr.oxfordjournals.org/
online.
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